Safety and Tolerability Study of ZEP-3 Cream (0.1% and 1.0%), Administered Topically In Healthy Volunteers

NCT01863160 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 0.1% ZEP-3 cream
DRUG: placebo

Sponsor

Shulov Innovate for Science Ltd. 2012